Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism

Published:2024-09 Issue: Volume:309 Page:122609
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Duan Yi,Deng Mengqiong,Liu Bin,Meng Xianwei^ORCID,Liao Jinghan,Qiu Yijie,Wu Zhihua,Lin Jiangtao^ORCID,Dong Yi^ORCID,Duan Yourong^ORCID,Sun Ying

Publisher

Elsevier BV

Reference66 articles.

1. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians;Moris;CA Cancer J Clin,2023

2. Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma;Merters;J. Hepatol.,2023

3. Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study;Javle;Lancet Gastroenterol Hepatol,2021

4. Landscape of clinical resistance mechanisms to FGFR inhibitors in FGFR2-altered cholangiocarcinoma;Wu;Clin. Cancer Res.,2024

5. Fat and Furious: lipid metabolism in antitumoral therapy response and resistance;Bacci;Trends Cancer,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP